Skip to main content
logo
Lantern Pharma Inc. (LTRN)
NASDAQ: LTRN · Real-Time Price · USD
1.973
-0.047 (-2.34%)
Sep 2, 2026, 1:27 PM EDT - Market open

Lantern Pharma Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-18.65-17.12-20.78-15.96-14.26-12.36
Depreciation & Amortization
0.240.210.190.170.150.1
Loss (Gain) From Sale of Investments
-0.03-0.26-0.4-0.180.70.22
Stock-Based Compensation
1.421.020.731.071.190.96
Other Operating Activities
3.4-0.160.220.010.06-0.11
Change in Accounts Payable
-0.580.271.64-0.240.581.62
Change in Other Net Operating Assets
0.080.360.590.77-1.19-1.02
Operating Cash Flow
-14.08-15.68-17.81-14.35-12.77-10.59
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-0-0-0.01-0.02-0.03-0.02
Investment in Securities
9.1711.063.38-0.910.21-19.52
Investing Cash Flow
9.1711.063.37-0.930.18-19.53

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Issuance of Common Stock
5.631.640.07-0.369.14
Repurchase of Common Stock
----0.5-2.48-0.94
Other Financing Activities
-0.14-0.14----4.78
Financing Cash Flow
5.491.50.07-0.5-2.1863.42

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
0.020.03-0.05-0.03-0.010
Net Cash Flow
0.6-3.09-14.43-15.81-14.7833.3

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-14.08-15.68-17.83-14.37-12.8-10.61
Free Cash Flow Growth
------
Free Cash Flow Per Share
-1.23-1.44-1.66-1.32-1.18-0.97
Levered Free Cash Flow
-8.24-9.18-10.54-8.7-8.68-5.56
Unlevered Free Cash Flow
-8.27-9.18-10.54-8.7-8.68-5.56

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Change in Working Capital
-0.50.642.230.54-0.610.6
SEC Filings: 10-K · 10-Q